Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Monte Rosa Therapeutics AG”

3 pharma patents match "Monte Rosa Therapeutics AG" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 3 pharmaceutical patents matching "Monte Rosa Therapeutics AG" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3 results for “Monte Rosa Therapeutics AG” · 30,257 patents in full index Clear search

  1. US 12391663

    Isoindolinone compounds

    Monte Rosa Therapeutics AG · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  2. US 12257247

    Targeted degradation of VAV1

    Monte Rosa Therapeutics AG · Granted Mar 25, 2025 · Expires Mar 20, 2045

    granted
  3. US 11912682

    Isoindolinone compounds

    Monte Rosa Therapeutics AG · Granted Feb 27, 2024 · Expires Feb 22, 2044

    granted